Clinical, Laboratory Features and Prognosis of Children Receiving IgM-enriched Immunoglobulin (3 Days vs. 5 Days) as Adjuvant Treatment for Serious Infectious Disease in Pediatric Intensive Care Unit: A Retrospective Single-Center Experience (PIGMENT Study)
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2019.1711298
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2020
Authors
Publisher
Informa UK Limited